DavosPharma

February 2011

DavosPharma’s corporate offering covers all the non-clinical activities required to get a drug from conception to commercialization. DavosPharma provides discovery chemistry & biology, pre-clinical development, DMPK, toxicology and all required CMC activities including custom synthesis of organic molecules, dosage form development, and manufacturing of cGMP intermediates, APIs, and drug product.

Contact

Giff Marzoni Vice President, Global Pharmaceutical Development Phone: 619-977-0120
Tony DelPrete Executive Vice President and CFO Phone: 201-995-0070
www.davos.com
555 Saturn Blvd. Ste B-420 San Diego, CA 92154 USA